146 results on '"Martinez-Hernandez, Eugenia"'
Search Results
2. Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort study
3. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
4. Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders
5. Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom
6. CD19-Directed CAR T-Cells in a Patient With Refractory MOGAD: Clinical and Immunologic Follow-Up for 1 Year.
7. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study
8. Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy
9. Frequency and relevance of IgM, and IgA antibodies against MOG in MOG-IgG-associated disease
10. MOG Antibodies Restricted to CSF in Children With Inflammatory CNS Disorders.
11. Blocking Placental Class G Immunoglobulin Transfer Prevents NMDA Receptor Antibody Effects in Newborn Mice
12. Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies
13. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis
14. Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies
15. Author Response: Clinical Significance of Anti-NMDAR Concurrent With Glial or Neuronal Surface Antibodies
16. Reduced serial dependence suggests deficits in synaptic potentiation in anti-NMDAR encephalitis and schizophrenia
17. Sleep disorders in anti-NMDAR encephalitis
18. Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatus
19. Post-mortem neuropathologic examination of a 5-case series of CAR T-cell treated patients
20. Post-mortem neuropathologic examination of a 6-case series of CAR T-cell treated patients
21. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies
22. Motor polyradiculopathy during pembrolizumab treatment of metastatic melanoma
23. Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes
24. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
25. Telemedicine for Monitoring MS Activity and Progression
26. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
27. Antibodies to Aquaporin 4, Myelin-Oligodendrocyte Glycoprotein, and the Glycine Receptor α1 Subunit in Patients With Isolated Optic Neuritis
28. Bulbar involvement in patients with antiganglioside antibodies against NeuNAc((alpha)2-3)Gal
29. Pregnancy outcomes in anti-NMDA receptor encephalitis: Case series
30. Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy
31. Encephalitis and antibodies to dipeptidyl-peptidase–like protein-6, a subunit of Kv4.2 potassium channels
32. Glycine Receptor Autoimmune Spectrum With Stiff-Man Syndrome Phenotype
33. Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID‐19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries.
34. Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis.
35. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.
36. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia
37. Identification of Novel Mutations in the SLC25A15 Gene in Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome: A Clinical, Molecular, and Functional Study
38. Limitations of a Commercial Assay as Diagnostic Test of Autoimmune Encephalitis.
39. Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study.
40. Cerebellar ataxia and autoantibodies restricted to glutamic acid decarboxylase 67 (GAD67)
41. Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis.
42. Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor.
43. DPPX antibody-associated encephalitis: Main syndrome and antibody effects.
44. DPPX antibody-associated encephalitis.
45. Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome.
46. Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder.
47. Autoimmune Septin-5 Disease Presenting as Spinocerebellar Ataxia and Nystagmus.
48. Analysis of autoantibodies against antigens of the inhibitory synapses in patients with non-paraneoplastic neurological syndromes and GAD65 antibodies
49. Encephalitis and antibodies to synaptic and neuronal cell surface proteins.
50. Orthostatic myoclonus associated with Caspr2 antibodies.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.